Posttraumatic growth modulates the response to negative emotions related to COVID‐19: An event‐related potentials study von Ng, Siuman, Xie, Weiyi, Gao, Junling, Wang, Man, Leung, Hank, Li, Huiyun, Sik, Hun Hung, Lau, Bobo Hi Po, Chan, Cecilia L. W.

Volltext

Improved Outcome in Children With Newly Diagnosed High-Risk Neuroblastoma Treated With Chemoimmunotherapy: Updated Results of a Phase II Study Using hu14.18K322A von Furman, Wayne L, McCarville, Beth, Shulkin, Barry L, Davidoff, Andrew, Krasin, Matthew, Hsu, Chia-Wei, Pan, Haitao, Wu, Jianrong, Brennan, Rachel, Bishop, Michael W, Helmig, Sara, Stewart, Elizabeth, Navid, Fariba, Triplett, Brandon, Santana, Victor, Santiago, Teresa, Hank, Jacquelyn A, Gillies, Stephen D, Yu, Alice, Sondel, Paul M, Leung, Wing H, Pappo, Alberto, Federico, Sara M

Volltext

A Pilot Trial of Humanized Anti-GD2 Monoclonal Antibody (hu14.18K322A) with Chemotherapy and Natural Killer Cells in Children with Recurrent/Refractory Neuroblastoma von Federico, Sara M, McCarville, M Beth, Shulkin, Barry L, Sondel, Paul M, Hank, Jacquelyn A, Hutson, Paul, Meagher, Michael, Shafer, Aaron, Ng, Catherine Y, Leung, Wing, Janssen, William E, Wu, Jianrong, Mao, Shenghua, Brennan, Rachel C, Santana, Victor M, Pappo, Alberto S, Furman, Wayne L

Volltext

A Phase II Trial of Hu14.18K322A in Combination with Induction Chemotherapy in Children with Newly Diagnosed High-Risk Neuroblastoma von Furman, Wayne L, Federico, Sara M, McCarville, Mary Beth, Shulkin, Barry L, Davidoff, Andrew M, Krasin, Matthew J, Sahr, Natasha, Sykes, April, Wu, Jianrong, Brennan, Rachel C, Bishop, Michael William, Helmig, Sara, Stewart, Elizabeth, Navid, Fariba, Triplett, Brandon, Santana, Victor M, Bahrami, Armita, Anthony, Gwendolyn, Yu, Alice L, Hank, Jacquelyn, Gillies, Stephen D, Sondel, Paul M, Leung, Wing H, Pappo, Alberto S

Volltext

Targeting KRAS Mutant Cancers via Combination Treatment: Discovery of a 5‑Fluoro-4-(3H)‑quinazolinone Aryl Urea pan-RAF Kinase Inhibitor von Huestis, Malcolm P, Dela Cruz, Darlene, DiPasquale, Antonio G, Durk, Matthew R, Eigenbrot, Charles, Gibbons, Paul, Gobbi, Alberto, Hunsaker, Thomas L, La, Hank, Leung, Dennis H, Liu, Wendy, Malek, Shiva, Merchant, Mark, Moffat, John G, Muli, Christine S, Orr, Christine J, Parr, Brendan T, Shanahan, Frances, Sneeringer, Christopher J, Wang, Weiru, Yen, Ivana, Yin, Jianping, Siu, Michael, Rudolph, Joachim

Volltext

Targeting KRAS Mutant Cancers via Combination Treatment: Discovery of a Pyridopyridazinone pan-RAF Kinase Inhibitor von Huestis, Malcolm P, Durk, Matthew R, Eigenbrot, Charles, Gibbons, Paul, Hunsaker, Thomas L, La, Hank, Leung, Dennis H, Liu, Wendy, Malek, Shiva, Merchant, Mark, Moffat, John G, Muli, Christine S, Orr, Christine J, Parr, Brendan T, Shanahan, Frances, Sneeringer, Christopher J, Wang, Weiru, Yen, Ivana, Yin, Jianping, Rudolph, Joachim, Siu, Michael

Volltext

Early response rates and Curie scores at end of induction: An update from a phase II study of an anti-GD2 monoclonal antibody (mAb) with chemotherapy (CT) in newly diagnosed patien... von Furman, Wayne Lee, Shulkin, Barry L., Federico, Sara Michele, McCarville, Mary B, Davidoff, Andrew M., Krasin, Matthew J., Wu, Jianrong, Brennan, Rachel Christine, Bishop, Michael William, Helmig, Sara E., Navid, Fariba, Santana, Victor M., Anthony, Gwendolyn, Hank, Jacquelyn A, Gillies, Stephen D, Sondel, Paul M., Leung, Wing H., Pappo, Alberto S.

Volltext

Prolonged interleukin-2 (IL-2) treatment can augment immune activation without enhancing antitumor activity in renal cell carcinoma von Sosman, J A, Hank, J A, Moore, K H, Borchert, A, Schell, K, Kohler, P C, Goldstein, D, Bechhofer, R, Storer, B, Albertini, M R

Volltext

Prolonged Interleukin-2 (IL-2) Treatment Can Augment Immune Activation Without Enhancing Antitumor Activity in Renal Cell Carcinom von Sosman, Jeff A., Hank, Jacquelyn A., Moore, Karen H., Borchert, Agnes, Schell, Kathleen, Kohler, Peter C., Goldstein, David, Bechhofer, Robin, Storer, Barry, Albertini, Mark R., Leung, Pearl E., Levitt, Daniel, Sondel, Paul M.

Volltext